Association of beta-2-microglobulin, cystatin C and lipocalin-2 with stroke risk in the general Chinese population
Beta-2-microglobulin (B2M), cystatin C and lipocalin-2 (LCN-2) are established renal biomarkers, yet their roles in stroke have not been fully evaluated. We aimed to investigate the relationship of B2M, cystatin C, and LCN-2 with stroke risk in a general Chinese population. We used ordinal regressio...
Gespeichert in:
| Veröffentlicht in: | Annals of medicine (Helsinki) 2023-12, Vol.55 (1), p.2203516-2203516 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2203516 |
|---|---|
| container_issue | 1 |
| container_start_page | 2203516 |
| container_title | Annals of medicine (Helsinki) |
| container_volume | 55 |
| creator | Zhen, Juanying Liu, Shuyun Kam, Ryan Yan Lam Zhao, Guoru Peng, Hao Liang, Jianguo Xu, Aimin Li, Chao Ren, Lijie Wu, Jun Cheung, Bernard Man Yung |
| description | Beta-2-microglobulin (B2M), cystatin C and lipocalin-2 (LCN-2) are established renal biomarkers, yet their roles in stroke have not been fully evaluated. We aimed to investigate the relationship of B2M, cystatin C, and LCN-2 with stroke risk in a general Chinese population.
We used ordinal regression to study the relationship between serum B2M, cystatin C, and LCN-2 with stroke risk in 1060 participants (mean age 45.4 ± 10.8 years, 46% male) from the Shenzhen-Hong Kong United Network on Cardiovascular Disease (SHUN-CVD) study. Stroke risk was classified into low-risk, middle-risk and high-risk groups according to the China National Stroke Screening Survey criteria. Serum biomarker levels were measured using immunoturbidimetric assays. Participants with valid data on serum biomarker levels and stroke risk were included in the analysis.
The number of participants in the low-risk, middle-risk and high-risk stroke risk groups were 663, 143 and 254 respectively. Elevated serum B2M, cystatin C, and LCN-2 levels were associated with being male, overweight/obesity, hypertension, alcohol consumption and smoking. Serum B2M, cystatin C and LCN-2 levels were significantly associated with stroke risk in the overall population (B2M: β = 0.595, p |
| doi_str_mv | 10.1080/07853890.2023.2203516 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_37155257</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_0cb27dfb89ce436ab12ae95a5d71b7b4</doaj_id><sourcerecordid>2811568820</sourcerecordid><originalsourceid>FETCH-LOGICAL-c535t-23e3b8d114b8efde45df25370b6f66839568ad3419f70006593d57dd0a874ef03</originalsourceid><addsrcrecordid>eNp9kUtvEzEUhUcIRNPCTwB5yYIJfozHnhVUEYVKldjA2vIzcevYwXao8u_xNGlFN6ws-X73nHt0uu4dgksEOfwEGaeET3CJISZLjCGhaHzRLRAZaY_hCF92i5npZ-isOy_lFkKIGYKvuzPCEKWYskWXL0tJ2svqUwTJAWWr7HG_9TqndUhqH3z8CPSh1IZEsAIyGhD8LmnZJj0G975uQKk53VmQfbkDjaobC9Y22iwDWG18tMWCXdrtw4PNm-6Vk6HYt6f3ovt19fXn6nt_8-Pb9erypteU0NpjYoniBqFBceuMHahxmBIG1ejGkZOJjlwaMqDJsZZspBMxlBkDJWeDdZBcdNdHXZPkrdhlv5X5IJL04uEj5bWQuXodrIBaYWac4pO2AxmlQljaiUpqGFJMDU3r81Frt1dba7SNtYV7Jvp8Ev1GrNMfgSAaGWe4KXw4KeT0e29LFVtftA1BRpv2RWCOUEvE8Xw4PaKtg1KydU8-CIq5fPFYvpjLF6fy2977f4982npsuwFfjoCPLuWtvE85GFHlIaTssozaF0H-7_EX7sS_ng</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2811568820</pqid></control><display><type>article</type><title>Association of beta-2-microglobulin, cystatin C and lipocalin-2 with stroke risk in the general Chinese population</title><source>Taylor & Francis Open Access</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Zhen, Juanying ; Liu, Shuyun ; Kam, Ryan Yan Lam ; Zhao, Guoru ; Peng, Hao ; Liang, Jianguo ; Xu, Aimin ; Li, Chao ; Ren, Lijie ; Wu, Jun ; Cheung, Bernard Man Yung</creator><creatorcontrib>Zhen, Juanying ; Liu, Shuyun ; Kam, Ryan Yan Lam ; Zhao, Guoru ; Peng, Hao ; Liang, Jianguo ; Xu, Aimin ; Li, Chao ; Ren, Lijie ; Wu, Jun ; Cheung, Bernard Man Yung</creatorcontrib><description>Beta-2-microglobulin (B2M), cystatin C and lipocalin-2 (LCN-2) are established renal biomarkers, yet their roles in stroke have not been fully evaluated. We aimed to investigate the relationship of B2M, cystatin C, and LCN-2 with stroke risk in a general Chinese population.
We used ordinal regression to study the relationship between serum B2M, cystatin C, and LCN-2 with stroke risk in 1060 participants (mean age 45.4 ± 10.8 years, 46% male) from the Shenzhen-Hong Kong United Network on Cardiovascular Disease (SHUN-CVD) study. Stroke risk was classified into low-risk, middle-risk and high-risk groups according to the China National Stroke Screening Survey criteria. Serum biomarker levels were measured using immunoturbidimetric assays. Participants with valid data on serum biomarker levels and stroke risk were included in the analysis.
The number of participants in the low-risk, middle-risk and high-risk stroke risk groups were 663, 143 and 254 respectively. Elevated serum B2M, cystatin C, and LCN-2 levels were associated with being male, overweight/obesity, hypertension, alcohol consumption and smoking. Serum B2M, cystatin C and LCN-2 levels were significantly associated with stroke risk in the overall population (B2M: β = 0.595, p < .001; cystatin C: β = 3.718, p < .001; LCN-2: β = 0.564, p < .001) after adjustment for age.
Elevated serum B2M, cystatin C and LCN-2 levels are associated with stroke risk. They may be novel biomarkers for clinicians to assess stroke risk.
Key messages
Serum beta-2-microglobulin, cystatin C and lipocalin-2 levels are significantly associated with stroke risk.
Beta-2-microglobulin, cystatin C and lipocalin-2 may serve as useful biomarkers for stroke risk stratification in the general population.</description><identifier>ISSN: 0785-3890</identifier><identifier>EISSN: 1365-2060</identifier><identifier>DOI: 10.1080/07853890.2023.2203516</identifier><identifier>PMID: 37155257</identifier><language>eng</language><publisher>England: Taylor & Francis</publisher><subject>Adult ; Beta-2-microglobulin ; Biomarkers ; Creatinine ; Cystatin C ; East Asian People ; Female ; Humans ; Lipocalin-2 ; Male ; Middle Aged ; Neurology ; Stroke - epidemiology ; Stroke - etiology ; stroke risk</subject><ispartof>Annals of medicine (Helsinki), 2023-12, Vol.55 (1), p.2203516-2203516</ispartof><rights>2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023</rights><rights>2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c535t-23e3b8d114b8efde45df25370b6f66839568ad3419f70006593d57dd0a874ef03</citedby><cites>FETCH-LOGICAL-c535t-23e3b8d114b8efde45df25370b6f66839568ad3419f70006593d57dd0a874ef03</cites><orcidid>0000-0001-6277-662X ; 0000-0001-9106-7363 ; 0000-0002-7113-3201 ; 0000-0002-7543-3973 ; 0000-0002-0668-033X ; 0009-0003-3047-9112 ; 0000-0001-9348-9236 ; 0000-0003-2563-3384 ; 0000-0001-8618-4709</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167872/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167872/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,27479,27901,27902,53766,53768,59116,59117</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37155257$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhen, Juanying</creatorcontrib><creatorcontrib>Liu, Shuyun</creatorcontrib><creatorcontrib>Kam, Ryan Yan Lam</creatorcontrib><creatorcontrib>Zhao, Guoru</creatorcontrib><creatorcontrib>Peng, Hao</creatorcontrib><creatorcontrib>Liang, Jianguo</creatorcontrib><creatorcontrib>Xu, Aimin</creatorcontrib><creatorcontrib>Li, Chao</creatorcontrib><creatorcontrib>Ren, Lijie</creatorcontrib><creatorcontrib>Wu, Jun</creatorcontrib><creatorcontrib>Cheung, Bernard Man Yung</creatorcontrib><title>Association of beta-2-microglobulin, cystatin C and lipocalin-2 with stroke risk in the general Chinese population</title><title>Annals of medicine (Helsinki)</title><addtitle>Ann Med</addtitle><description>Beta-2-microglobulin (B2M), cystatin C and lipocalin-2 (LCN-2) are established renal biomarkers, yet their roles in stroke have not been fully evaluated. We aimed to investigate the relationship of B2M, cystatin C, and LCN-2 with stroke risk in a general Chinese population.
We used ordinal regression to study the relationship between serum B2M, cystatin C, and LCN-2 with stroke risk in 1060 participants (mean age 45.4 ± 10.8 years, 46% male) from the Shenzhen-Hong Kong United Network on Cardiovascular Disease (SHUN-CVD) study. Stroke risk was classified into low-risk, middle-risk and high-risk groups according to the China National Stroke Screening Survey criteria. Serum biomarker levels were measured using immunoturbidimetric assays. Participants with valid data on serum biomarker levels and stroke risk were included in the analysis.
The number of participants in the low-risk, middle-risk and high-risk stroke risk groups were 663, 143 and 254 respectively. Elevated serum B2M, cystatin C, and LCN-2 levels were associated with being male, overweight/obesity, hypertension, alcohol consumption and smoking. Serum B2M, cystatin C and LCN-2 levels were significantly associated with stroke risk in the overall population (B2M: β = 0.595, p < .001; cystatin C: β = 3.718, p < .001; LCN-2: β = 0.564, p < .001) after adjustment for age.
Elevated serum B2M, cystatin C and LCN-2 levels are associated with stroke risk. They may be novel biomarkers for clinicians to assess stroke risk.
Key messages
Serum beta-2-microglobulin, cystatin C and lipocalin-2 levels are significantly associated with stroke risk.
Beta-2-microglobulin, cystatin C and lipocalin-2 may serve as useful biomarkers for stroke risk stratification in the general population.</description><subject>Adult</subject><subject>Beta-2-microglobulin</subject><subject>Biomarkers</subject><subject>Creatinine</subject><subject>Cystatin C</subject><subject>East Asian People</subject><subject>Female</subject><subject>Humans</subject><subject>Lipocalin-2</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Stroke - epidemiology</subject><subject>Stroke - etiology</subject><subject>stroke risk</subject><issn>0785-3890</issn><issn>1365-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>EIF</sourceid><sourceid>DOA</sourceid><recordid>eNp9kUtvEzEUhUcIRNPCTwB5yYIJfozHnhVUEYVKldjA2vIzcevYwXao8u_xNGlFN6ws-X73nHt0uu4dgksEOfwEGaeET3CJISZLjCGhaHzRLRAZaY_hCF92i5npZ-isOy_lFkKIGYKvuzPCEKWYskWXL0tJ2svqUwTJAWWr7HG_9TqndUhqH3z8CPSh1IZEsAIyGhD8LmnZJj0G975uQKk53VmQfbkDjaobC9Y22iwDWG18tMWCXdrtw4PNm-6Vk6HYt6f3ovt19fXn6nt_8-Pb9erypteU0NpjYoniBqFBceuMHahxmBIG1ejGkZOJjlwaMqDJsZZspBMxlBkDJWeDdZBcdNdHXZPkrdhlv5X5IJL04uEj5bWQuXodrIBaYWac4pO2AxmlQljaiUpqGFJMDU3r81Frt1dba7SNtYV7Jvp8Ev1GrNMfgSAaGWe4KXw4KeT0e29LFVtftA1BRpv2RWCOUEvE8Xw4PaKtg1KydU8-CIq5fPFYvpjLF6fy2977f4982npsuwFfjoCPLuWtvE85GFHlIaTssozaF0H-7_EX7sS_ng</recordid><startdate>20231212</startdate><enddate>20231212</enddate><creator>Zhen, Juanying</creator><creator>Liu, Shuyun</creator><creator>Kam, Ryan Yan Lam</creator><creator>Zhao, Guoru</creator><creator>Peng, Hao</creator><creator>Liang, Jianguo</creator><creator>Xu, Aimin</creator><creator>Li, Chao</creator><creator>Ren, Lijie</creator><creator>Wu, Jun</creator><creator>Cheung, Bernard Man Yung</creator><general>Taylor & Francis</general><general>Taylor & Francis Group</general><scope>0YH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-6277-662X</orcidid><orcidid>https://orcid.org/0000-0001-9106-7363</orcidid><orcidid>https://orcid.org/0000-0002-7113-3201</orcidid><orcidid>https://orcid.org/0000-0002-7543-3973</orcidid><orcidid>https://orcid.org/0000-0002-0668-033X</orcidid><orcidid>https://orcid.org/0009-0003-3047-9112</orcidid><orcidid>https://orcid.org/0000-0001-9348-9236</orcidid><orcidid>https://orcid.org/0000-0003-2563-3384</orcidid><orcidid>https://orcid.org/0000-0001-8618-4709</orcidid></search><sort><creationdate>20231212</creationdate><title>Association of beta-2-microglobulin, cystatin C and lipocalin-2 with stroke risk in the general Chinese population</title><author>Zhen, Juanying ; Liu, Shuyun ; Kam, Ryan Yan Lam ; Zhao, Guoru ; Peng, Hao ; Liang, Jianguo ; Xu, Aimin ; Li, Chao ; Ren, Lijie ; Wu, Jun ; Cheung, Bernard Man Yung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c535t-23e3b8d114b8efde45df25370b6f66839568ad3419f70006593d57dd0a874ef03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adult</topic><topic>Beta-2-microglobulin</topic><topic>Biomarkers</topic><topic>Creatinine</topic><topic>Cystatin C</topic><topic>East Asian People</topic><topic>Female</topic><topic>Humans</topic><topic>Lipocalin-2</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Stroke - epidemiology</topic><topic>Stroke - etiology</topic><topic>stroke risk</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhen, Juanying</creatorcontrib><creatorcontrib>Liu, Shuyun</creatorcontrib><creatorcontrib>Kam, Ryan Yan Lam</creatorcontrib><creatorcontrib>Zhao, Guoru</creatorcontrib><creatorcontrib>Peng, Hao</creatorcontrib><creatorcontrib>Liang, Jianguo</creatorcontrib><creatorcontrib>Xu, Aimin</creatorcontrib><creatorcontrib>Li, Chao</creatorcontrib><creatorcontrib>Ren, Lijie</creatorcontrib><creatorcontrib>Wu, Jun</creatorcontrib><creatorcontrib>Cheung, Bernard Man Yung</creatorcontrib><collection>Taylor & Francis Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Annals of medicine (Helsinki)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhen, Juanying</au><au>Liu, Shuyun</au><au>Kam, Ryan Yan Lam</au><au>Zhao, Guoru</au><au>Peng, Hao</au><au>Liang, Jianguo</au><au>Xu, Aimin</au><au>Li, Chao</au><au>Ren, Lijie</au><au>Wu, Jun</au><au>Cheung, Bernard Man Yung</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of beta-2-microglobulin, cystatin C and lipocalin-2 with stroke risk in the general Chinese population</atitle><jtitle>Annals of medicine (Helsinki)</jtitle><addtitle>Ann Med</addtitle><date>2023-12-12</date><risdate>2023</risdate><volume>55</volume><issue>1</issue><spage>2203516</spage><epage>2203516</epage><pages>2203516-2203516</pages><issn>0785-3890</issn><eissn>1365-2060</eissn><abstract>Beta-2-microglobulin (B2M), cystatin C and lipocalin-2 (LCN-2) are established renal biomarkers, yet their roles in stroke have not been fully evaluated. We aimed to investigate the relationship of B2M, cystatin C, and LCN-2 with stroke risk in a general Chinese population.
We used ordinal regression to study the relationship between serum B2M, cystatin C, and LCN-2 with stroke risk in 1060 participants (mean age 45.4 ± 10.8 years, 46% male) from the Shenzhen-Hong Kong United Network on Cardiovascular Disease (SHUN-CVD) study. Stroke risk was classified into low-risk, middle-risk and high-risk groups according to the China National Stroke Screening Survey criteria. Serum biomarker levels were measured using immunoturbidimetric assays. Participants with valid data on serum biomarker levels and stroke risk were included in the analysis.
The number of participants in the low-risk, middle-risk and high-risk stroke risk groups were 663, 143 and 254 respectively. Elevated serum B2M, cystatin C, and LCN-2 levels were associated with being male, overweight/obesity, hypertension, alcohol consumption and smoking. Serum B2M, cystatin C and LCN-2 levels were significantly associated with stroke risk in the overall population (B2M: β = 0.595, p < .001; cystatin C: β = 3.718, p < .001; LCN-2: β = 0.564, p < .001) after adjustment for age.
Elevated serum B2M, cystatin C and LCN-2 levels are associated with stroke risk. They may be novel biomarkers for clinicians to assess stroke risk.
Key messages
Serum beta-2-microglobulin, cystatin C and lipocalin-2 levels are significantly associated with stroke risk.
Beta-2-microglobulin, cystatin C and lipocalin-2 may serve as useful biomarkers for stroke risk stratification in the general population.</abstract><cop>England</cop><pub>Taylor & Francis</pub><pmid>37155257</pmid><doi>10.1080/07853890.2023.2203516</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-6277-662X</orcidid><orcidid>https://orcid.org/0000-0001-9106-7363</orcidid><orcidid>https://orcid.org/0000-0002-7113-3201</orcidid><orcidid>https://orcid.org/0000-0002-7543-3973</orcidid><orcidid>https://orcid.org/0000-0002-0668-033X</orcidid><orcidid>https://orcid.org/0009-0003-3047-9112</orcidid><orcidid>https://orcid.org/0000-0001-9348-9236</orcidid><orcidid>https://orcid.org/0000-0003-2563-3384</orcidid><orcidid>https://orcid.org/0000-0001-8618-4709</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0785-3890 |
| ispartof | Annals of medicine (Helsinki), 2023-12, Vol.55 (1), p.2203516-2203516 |
| issn | 0785-3890 1365-2060 |
| language | eng |
| recordid | cdi_pubmed_primary_37155257 |
| source | Taylor & Francis Open Access; MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Adult Beta-2-microglobulin Biomarkers Creatinine Cystatin C East Asian People Female Humans Lipocalin-2 Male Middle Aged Neurology Stroke - epidemiology Stroke - etiology stroke risk |
| title | Association of beta-2-microglobulin, cystatin C and lipocalin-2 with stroke risk in the general Chinese population |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T09%3A03%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20beta-2-microglobulin,%20cystatin%20C%20and%20lipocalin-2%20with%20stroke%20risk%20in%20the%20general%20Chinese%20population&rft.jtitle=Annals%20of%20medicine%20(Helsinki)&rft.au=Zhen,%20Juanying&rft.date=2023-12-12&rft.volume=55&rft.issue=1&rft.spage=2203516&rft.epage=2203516&rft.pages=2203516-2203516&rft.issn=0785-3890&rft.eissn=1365-2060&rft_id=info:doi/10.1080/07853890.2023.2203516&rft_dat=%3Cproquest_pubme%3E2811568820%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2811568820&rft_id=info:pmid/37155257&rft_doaj_id=oai_doaj_org_article_0cb27dfb89ce436ab12ae95a5d71b7b4&rfr_iscdi=true |